https://www.biospace.com/b-a-href-company-profile-aspx-companyid-1376-fda-a-b-seeks-to-halt-b-a-href-company-profile-aspx-companyid-48304-font-color-999966-astr
fdaseekshaltastrazenecaad
https://www.biospace.com/zymeworks-announces-participation-in-upcoming-investor-conferences-february-28-2023
Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that management will...
investor conferenceszymeworksannouncesparticipationupcoming
https://www.biospace.com/semathera-enters-into-a-research-collaboration-and-exclusive-license-agreement-with-roche
SemaThera Inc. today announced the signing of a multi-year research collaboration and licensing agreement with Roche. The partnership will focus on developing...
research collaborationexclusive licenseentersagreement
https://www.biospace.com/the-cigna-group-to-host-investor-day-in-new-york-city-on-march-7
Global health company The Cigna Group (NYSE:CI) will be hosting its Investor Day on Thursday, March 7, 2024 in New York City.
cigna groupinvestor daynew yorkhost
https://www.biospace.com/ge-healthcare-to-showcase-latest-ai-innovations-at-himss-2023
GE HealthCare (Nasdaq: GEHC), a leader in health technology, will showcase its growing portfolio of digital platforms and solutions at the Health Information...
ge healthcarelatest aishowcaseinnovationshimss
https://www.biospace.com/heat-biologics-provides-business-update
Heat Biologics, Inc. today announced a planned reverse stock split of its shares of common stock at a ratio of 1-for-7. The reverse stock split will take...
heat biologicsbusiness updateprovidesbiospace
https://www.biospace.com/game-may-not-be-over-for-royalty-pharma-s-bid-for-elan-corporation-plc
royalty pharmagamemaybid
https://www.biospace.com/microbot-medical-expand-ip-protection-in-japan
Microbot Medical Inc. announced the expansion of its global IP portfolio by receiving a Grant of Protection from the Japan Patent Office for a Design Patent...
ip protectionmicrobotmedicalexpandjapan
https://www.biospace.com/global-hemp-group-announces-jeff-nagel-as-product-manufacturing-advisor
GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) ("GHG" or the "Company") is pleased to announce that Jeff Nagel has joined the Company's...
global hempproduct manufacturinggroupannouncesjeff
https://www.biospace.com/city-of-hope-invests-1-billion-plus-in-comprehensive-cancer-center
City of Hope announced plans to build a new comprehensive cancer campus at FivePoint Gateway in Orange County. As part of that plan, it will invest more than...
cityhopeinvestsbillionplus
https://www.biospace.com/genflow-biosciences-plc-announces-strengthening-of-pre-clinical-efforts
Genflow Biosciences Strengthens Pre-Clinical Efforts with FDA Guidance and CDMO and CRO Selection
pre clinicalbiosciencesplcannouncesstrengthening
https://www.biospace.com/cue-biopharma-to-present-at-two-upcoming-investor-healthcare-conferences-in-november-2021
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics designed to selectively engage and modulate...
cuebiopharmapresenttwoupcoming
https://www.biospace.com/boryung-pharmaceutical-korea-increases-production-efficiency-thanks-to-aflex-hose
Aflex Hose from Watson-Marlow Fluid Technology Group is being used to manufacture Gelfos, the leading antacid medication in Korea, China and Taiwan
production efficiencyboryungpharmaceuticalkoreaincreases
https://www.biospace.com/mereo-biopharma-received-notification-of-nasdaq-minimum-bid-price-deficiency
Mereo BioPharma Group plc announced that on May 23, 2022, it received a notification letter from the Listing Qualifications Department of the Nasdaq Stock...
bid pricebiopharmareceivednotificationnasdaq
https://www.biospace.com/cellectis-and-cytovia-partner-to-develop-natural-killer-cells
Shares of Cellectis Therapeutics were up nearly 10% in premarket trading after the company forged a deal with Cytovia Therapeutics to develop immunotherapies...
natural killer cellcellectisstockjumpsfollowing
https://www.biospace.com/b-impliant-b-unveils-tops-tm-system-at-b-spine-arthroplasty-society-b-meeting
unveilstopstmsystemspine
https://www.biospace.com/pharming-group-to-participate-in-september-2023-investor-conferences
Pharming Group N.V. announces that Pharming's management will participate in the following investor conferences in the U.S. in the month of September.
investor conferencespharminggroupparticipateseptember
https://www.biospace.com/bristol-myers-squibb-announces-dividend-increase-dec-10-2020
Bristol Myers Squibb announced that its Board of Directors has declared a quarterly dividend of forty-nine cents per share on the $.10 par value common stock...
bristol myers squibbannouncesdividendincreasedec
https://www.biospace.com/genialis-biolab-partner-to-improve-precision-medicine-using-data-mining
Genialis, a leader in applied data science for the development of precision medicines, today announced together with the Bioinformatics Laboratory at the...
precision medicineusing datagenialisbiolabpartner
https://www.biospace.com/metrodora-institute-announces-healthcare-and-biotech-leader-john-b-wirthlin-as-ceo
Metrodora Institute, an innovative medical and research center dedicated to advancing care, treatments, and cures for people living with complex, chronic...
metrodora institutejohn bannounceshealthcarebiotech